The present invention is drawn to novel antiviral compounds,
pharmaceutical compositions and their use. More specifically this
invention is drawn to derivatives of monocyclic polyamines which have
activity in standard tests against HIV-infected cells as well as other
biological activity related to binding of ligands to chemokine receptors
that mediate a number of mammalian embryonic developmental processes.